Core A: Administrative Core
Core A: Administrative Core
批准号:
10381474
负责人:
Michael R. Farzan
金额:
$56.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-15 至 2023-02-28
关键词:
AntibodiesCellsCollaborationsCommittee MembersCommunicationConsultDecision MakingDependovirusDisease remissionEnsureFinancial SupportGoalsImmune systemIndividualLogisticsMacacaMacaca mulattaManuscriptsMediatingNational Institute of Allergy and Infectious DiseasePersonsPreventionPrimatesPublicationsReportingResearch PersonnelResourcesRoleSIVSiteUnited States National Institutes of HealthVirus Diseasesadeno-associated viral vectoranimal careantiretroviral therapycostdesignexperienceexperimental studyinhibitormeetingsmembernonhuman primateoperationprogramssimian human immunodeficiency virussymposium
中文摘要
项目摘要(核心A--行政核心)
这项建议的总体目标是:(1)建立健壮、一致和安全的无艺术状态
SIV和SIV感染恒河猴通过持续表达
抗体和抗体样抑制物,(2)了解猕猴免疫系统和
抗逆转录病毒治疗促进这些功能性治疗,以及(3)确定这些功能性治疗是否可以
也有助于加速潜伏感染细胞储存库的腐烂。行政核心意志
提供一切必要的后勤、科学、管理、统计、监管和财政支持
促进和协调本计划的研究,从而确保这些目标的顺利完成。
行政核心还将设立一个具有广泛代表性的管理委员会并为其活动提供便利
非人灵长类研究和腺相关病毒(AAV)载体应用于
病毒感染的治疗和预防。这个管理委员会将每季度召开一次会议,两次
被任命为科学顾问和NIH项目官员,并两次独立。行政核心
威尔促成了这些会议。核心还将通过涵盖以下内容促进跨项目协作
涉及多项目合作的所有手稿的出版费用对本组织的目标至关重要
建议,并确保对本计划中描述的所有研究提供统计支持。最后,核心将
负责遵守动物护理和使用、财务和报告要求
与此计划相关联。
英文摘要
PROJECT SUMMARY (Core A – Administrative Core)
The general goals of this proposal are: (1) to establish robust, consistent, and safe states of ART-free
remission (‘functional cures’) in SHIV- and SIV-infected rhesus macaques through sustained expression of
antibodies and antibody-like inhibitors, (2) to understand the role of the macaque immune system and
antiretroviral therapy in facilitating these functional cures, and (3) to determine if these functional cures can
also help accelerate the decay of the reservoir of latently infected cells. The Administrative Core will
provide all the logistic, scientific, managerial, statistical, regulatory and financial support necessary to
facilitate and coordinate the studies of this program, thus ensuring the successful completion of these goals.
The Administrative Core will also establish and facilitate the activities of a Governing Committee with broad
experience in non-human primate studies and in the application of adeno-associated virus (AAV) vectors to
the treatment and prevention of viral infection. This Governing Committee will meet quarterly, twice with an
appointed Scientific Advisory and NIH Program officials, and twice independently. The Administrative Core
will facilitated these meetings. The Core will also promote cross-project collaborations by covering the
publication costs of all manuscripts involving multi-project collaborations central to the goals of this
proposal, and ensure statistical support for all studies described in this program. Finally the Core will
assume responsibility for compliance with animal care and use, financial, and reporting requirements
associated with this program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
eCD4-mediated control of SIV infection in the brain
-
批准号:10698442
-
项目类别:
-
资助金额:$91.41万
-
财政年份:2023
-
负责人:Michael R. Farzan
-
依托单位:
Safe, CRISPR/Cas-free B cell editing for therapeutic applications
-
批准号:10725412
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2023
-
负责人:Michael R. Farzan
-
依托单位:
Improving mRNA vaccines with extracellular vesicle-associated immunogens
-
批准号:10573644
-
项目类别:
-
资助金额:$8.28万
-
财政年份:2022
-
负责人:Michael R. Farzan
-
依托单位:
Improving mRNA vaccines with extracellular vesicle-associated immunogens
-
批准号:10850617
-
项目类别:
-
资助金额:$18.96万
-
财政年份:2022
-
负责人:Michael R. Farzan
-
依托单位:
Targeting druggable coronavirus proteins
-
批准号:10514326
-
项目类别:
-
资助金额:$578.68万
-
财政年份:2022
-
负责人:Michael R. Farzan
-
依托单位:
Engineering CAR-B cells for an HIV-1 functional cure
-
批准号:10514882
-
项目类别:
-
资助金额:$69.5万
-
财政年份:2022
-
负责人:Michael R. Farzan
-
依托单位:
Engineering CAR-B cells for an HIV-1 functional cure
-
批准号:10844837
-
项目类别:
-
资助金额:$74.11万
-
财政年份:2022
-
负责人:Michael R. Farzan
-
依托单位:
Therapeutic Use of an Enhanced Form of CD4-Ig
-
批准号:9970576
-
项目类别:
-
资助金额:$92.43万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
Eliciting tyrosine-sulfated neutralizing antibodies recognizing the Env apex
-
批准号:10013483
-
项目类别:
-
资助金额:$23.13万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
Therapeutic use of an enhanced form of CD4-Ig
-
批准号:10851165
-
项目类别:
-
资助金额:$20.01万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
Core B: Non-human primate core
-
批准号:10625274
-
项目类别:
-
资助金额:$55.2万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
Project 4: A permanent off-switch for AAV
-
批准号:10625294
-
项目类别:
-
资助金额:$35.43万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
Therapeutic Use of an Enhanced Form of CD4-Ig
-
批准号:10591713
-
项目类别:
-
资助金额:$27.53万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
Therapeutic Use of an Enhanced Form of CD4-Ig
-
批准号:10534766
-
项目类别:
-
资助金额:$72.17万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
An AAV-mediated functional cure and its impact on the reservoir
-
批准号:10625272
-
项目类别:
-
资助金额:$260.96万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
Core A: Administrative Core
-
批准号:10625273
-
项目类别:
-
资助金额:$4.7万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
Core B: Non-human primate core
-
批准号:10381475
-
项目类别:
-
资助金额:$60.27万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
An AAV-mediated functional cure and its impact on the reservoir
-
批准号:10381472
-
项目类别:
-
资助金额:$313.69万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
Project 4: A permanent off-switch for AAV
-
批准号:10381480
-
项目类别:
-
资助金额:$67.16万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
An AAV-mediated functional cure and its impact on the reservoir
-
批准号:9891590
-
项目类别:
-
资助金额:$293.89万
-
财政年份:2020
-
负责人:Michael R. Farzan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: